A&P Lifescience Fund A FI

A&P Lifescience Fund FI primarily invests over three-quarters of its portfolio in international stocks, focusing mainly on the biotechnology and healthcare sectors. This includes a diverse range of companies such as innovative small biotech firms, generic drug manufacturers, large pharmaceutical companies, medical device makers, hospital service providers, and insurance firms. The fund targets companies from OECD countries but can allocate up to 30% of its investments to non-OECD and emerging markets, predominantly choosing small and medium-sized enterprises. The remaining portion of the portfolio is allocated to public and private fixed income instruments, ensuring liquidity and diversification without specific credit or quality restrictions.